Christine Ring
CLO at Nurix Therapeutics NRIX
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Oct 30, 2026 | Nurix Therapeutics NRIX | Option exercise 3,750 sh 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. | 12,860 | 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. | |
| Oct 30, 2026 | Nurix Therapeutics NRIX | Option exercise 2,859 sh 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. | 15,719 | 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. | |
| Oct 30, 2026 | Nurix Therapeutics NRIX | Option exercise 3,573 sh 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. | 19,292 | 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. | |
| Oct 30, 2026 | Nurix Therapeutics NRIX | Sold 3,957 sh at $26.28 The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. | $104K | 15,335 −21% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Oct 30, 2025 | Nurix Therapeutics NRIX | Option exercise 1,924 sh 8 days after the company's 8-K filed Oct 22, 2025. | 45,933 | 8 days after the company's 8-K filed Oct 22, 2025. | |
| Oct 30, 2025 | Nurix Therapeutics NRIX | Option exercise 2,000 sh 8 days after the company's 8-K filed Oct 22, 2025. | 47,933 | 8 days after the company's 8-K filed Oct 22, 2025. | |
| Oct 30, 2025 | Nurix Therapeutics NRIX | Option exercise 3,750 sh 8 days after the company's 8-K filed Oct 22, 2025. | 51,683 | 8 days after the company's 8-K filed Oct 22, 2025. | |
| Oct 30, 2025 | Nurix Therapeutics NRIX | Option exercise 2,858 sh 8 days after the company's 8-K filed Oct 22, 2025. | 54,541 | 8 days after the company's 8-K filed Oct 22, 2025. | |
| Oct 30, 2025 | Nurix Therapeutics NRIX | Sold 3,644 sh at $12.80 The filing does not mark this sale as under a Rule 10b5-1 plan. 8 days after the company's 8-K filed Oct 22, 2025. | $47K | 50,897 −7% | The filing does not mark this sale as under a Rule 10b5-1 plan. 8 days after the company's 8-K filed Oct 22, 2025. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.